InsidersTradesSigma
Total declarations
Company
▲ Purchases (16 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by KAZIMI A J. Insider active across 1 companies, notably Cumberland Pharmaceuticals INC. In total, 19 filings have been published. Total volume traded: €650. The latest transaction was disclosed on 16 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
€47,22220,000 shares@ €2.36110.058% mcap18.9% of flow
Common Stock
SEC:0001209191-22-026135:0·
€6618 shares@ €3.65390.0001% mcap0.1% of flow
Common Stock
SEC:0001209191-22-002457·
Ideal exit: 28 Aug 2022 (T+270)
€6618 shares@ €3.65390.0001% mcap0.0% of flow
Common Stock
SEC:0001209191-22-002457:0·
Ideal exit: 28 Aug 2022 (T+270)
€3515 shares@ €2.31040.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-067888·
Ideal exit: 29 Jul 2022 (T+270)
€3515 shares@ €2.31040.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-067888:0·
Ideal exit: 29 Jul 2022 (T+270)
€3515 shares@ €2.32410.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-063222·
Ideal exit: 28 Jun 2022 (T+270)
€3515 shares@ €2.32410.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-063222:0·
Ideal exit: 28 Jun 2022 (T+270)
€3615 shares@ €2.43220.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-058517·
Ideal exit: 29 May 2022 (T+270)
€3615 shares@ €2.43220.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-058517:0·
Ideal exit: 29 May 2022 (T+270)
€4215 shares@ €2.81270.0001% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055507·
Ideal exit: 29 Apr 2022 (T+270)
€3815 shares@ €2.5310.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055496·
Ideal exit: 11 Jan 2022 (T+270)
€3615 shares@ €2.4030.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055500·
Ideal exit: 22 Feb 2022 (T+270)
€3715 shares@ €2.45650.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055504·
Ideal exit: 28 Mar 2022 (T+270)
€3815 shares@ €2.5310.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055496:0·
Ideal exit: 11 Jan 2022 (T+270)
€3715 shares@ €2.45650.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055504:0·
Ideal exit: 28 Mar 2022 (T+270)
€3615 shares@ €2.4030.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055500:0·
Ideal exit: 22 Feb 2022 (T+270)
€4215 shares@ €2.81270.0001% mcap0.0% of flow
Common Stock
SEC:0001209191-21-055507:0·
Ideal exit: 29 Apr 2022 (T+270)
€101,05137,350 shares@ €2.70550.12% mcap40.4% of flow
Common Stock
SEC:0001209191-21-039928:0·
€101,05137,350 shares@ €2.70550.12% mcap99.7% of flow
Common Stock
SEC:0001209191-21-039928·
19 of 19 declarations
About KAZIMI A J
Kazimi A J is an executive at Cumberland Pharmaceuticals Inc.
